Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

TransCon CNP matches BioMarin's Voxzogo for achondroplasia with plans for regulatory filings in 2025, showing potential for ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

As Amanda Phommachanh, a 45-year-old realtor in Manassas, Virginia, describes it, she was on track with Wegovy to meet her ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...